Document is current
Any future updates will be listed below
-
Authors
Weber, Sophia J. https://orcid.org/0000-0002-0845-7385
Kawa, Alex B.
Beutler, Madelyn M.
Kuhn, Hayley M.
Moutier, Alana L.
Westlake, Jonathan G.
Koyshman, Lara M.
Moreno, Cloe D.
Wunsch, Amanda M. https://orcid.org/0000-0002-2292-439X
Wolf, Marina E.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (F31 DA057063, T32 DA007262, K99-R00 DA057360, DA049930)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- License Information
-
More Information
Article History
Received: 10 May 2024
Revised: 30 August 2024
Accepted: 7 September 2024
First Online: 19 September 2024
Competing interests
: MEW and OHSU have a financial interest in Eleutheria Pharmaceuticals LLC, a company that may have a commercial interest in results related to the research described herein. This potential conflict of interest has been reviewed and managed by OHSU. Wolf also serves as a Consultant for the University of Texas-Austin and has received compensation. The other authors declare no competing interests.
